Correlation Between YS Biopharma and Allarity Therapeutics
Can any of the company-specific risk be diversified away by investing in both YS Biopharma and Allarity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining YS Biopharma and Allarity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between YS Biopharma Co, and Allarity Therapeutics, you can compare the effects of market volatilities on YS Biopharma and Allarity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in YS Biopharma with a short position of Allarity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of YS Biopharma and Allarity Therapeutics.
Diversification Opportunities for YS Biopharma and Allarity Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between YS Biopharma and Allarity is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding YS Biopharma Co, and Allarity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allarity Therapeutics and YS Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on YS Biopharma Co, are associated (or correlated) with Allarity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allarity Therapeutics has no effect on the direction of YS Biopharma i.e., YS Biopharma and Allarity Therapeutics go up and down completely randomly.
Pair Corralation between YS Biopharma and Allarity Therapeutics
Allowing for the 90-day total investment horizon YS Biopharma Co, is expected to generate 1.0 times more return on investment than Allarity Therapeutics. However, YS Biopharma is 1.0 times more volatile than Allarity Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Allarity Therapeutics is currently generating about -0.27 per unit of risk. If you would invest 145.00 in YS Biopharma Co, on August 27, 2024 and sell it today you would lose (97.00) from holding YS Biopharma Co, or give up 66.9% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 77.48% |
| Values | Daily Returns |
YS Biopharma Co, vs. Allarity Therapeutics
Performance |
| Timeline |
| YS Biopharma Co, |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Allarity Therapeutics |
YS Biopharma and Allarity Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with YS Biopharma and Allarity Therapeutics
The main advantage of trading using opposite YS Biopharma and Allarity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if YS Biopharma position performs unexpectedly, Allarity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will offset losses from the drop in Allarity Therapeutics' long position.| YS Biopharma vs. Revelation Biosciences | YS Biopharma vs. Cardio Diagnostics Holdings | YS Biopharma vs. Biodexa Pharmaceticals | YS Biopharma vs. ZyVersa Therapeutics |
| Allarity Therapeutics vs. Immix Biopharma | Allarity Therapeutics vs. Cns Pharmaceuticals | Allarity Therapeutics vs. Sonnet Biotherapeutics Holdings | Allarity Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |